Back to results
US 2026/0053818 A1Published application
Pharmaceutical formulation for the treatment of inflammatory changes to the rectum
AssigneeDr. Falk Pharma GmbH
InventorsRudolf WILHELM, Markus PRÖLS, Roland GREINWALD, Ralf MOHRBACHER
Life of this patent
Estimating the term…
Abstract
Disclosed is a storage-stable pharmaceutical formulation for rectal administration, containing budesonide or a pharmaceutically compatible salt or derivative thereof, and at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of the formulation, as well as at least one anti-oxidation agent that is compatible therewith.
Claims23
A pharmaceutical formulation, comprising budesonide or pharmaceutically compatible salt or derivative thereof;
- at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of the formulation, and at least one anti-oxidation agent, wherein the budesonide is present in a micronized form, wherein 100% of the particles are smaller than 10 μm per particle, and wherein the weight ratio of budesonide to formulation mass is between 1-10 to 1000.
Dependencies are inferred from the claim text.